Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.33 is 33% above its 5-year average of -3.46, near the high end of its 5-year range (-12.80–-0.07).
70.13% above its 12-month average of -7.80.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.64.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:51:40.518Z. Historical observations retain their original dates. Historical series through 2015-08-06.
EARNINGS PER SHARE (EPS)
-2.33
EARNINGS PER SHARE (EPS) AVG TTM
-7.80
EARNINGS PER SHARE (EPS) AVG 3Y
-4.68
EARNINGS PER SHARE (EPS) AVG 5Y
-3.46
EARNINGS PER SHARE (EPS) AVG 10Y
-2.75
EARNINGS PER SHARE (EPS) AVG 15Y
-0.72
EARNINGS PER SHARE (EPS) AVG 20Y
-0.75
CURRENT VS TTM AVG
+70.13%
CURRENT VS 3Y AVG
+50.17%
CURRENT VS 5Y AVG
+32.71%
CURRENT VS 10Y AVG
+15.13%
CURRENT VS 15Y AVG
-222.20%
CURRENT VS 20Y AVG
-212.75%
Harvard Bioscience, Inc.
Market Cap
$38.98M
Earnings Per Share (EPS)
-2.33
TTM Avg
-7.80
3Y Avg
-4.68
5Y Avg
-3.46
Market Cap
$38.11M
Earnings Per Share (EPS)
0.16
TTM Avg
0.06
3Y Avg
-0.19
5Y Avg
-0.28
Market Cap
$39.15M
Earnings Per Share (EPS)
-2.49
TTM Avg
-2.22
3Y Avg
-1.86
5Y Avg
-2.21
Market Cap
$37.73M
Earnings Per Share (EPS)
N/A
TTM Avg
-21.23
3Y Avg
-13.85
5Y Avg
-9.58
Market Cap
$40.05M
Earnings Per Share (EPS)
-0.60
TTM Avg
-2.17
3Y Avg
-6.45
5Y Avg
-4.61
Market Cap
$36.61M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
Market Cap
$40.47M
Earnings Per Share (EPS)
-0.87
TTM Avg
-1.21
3Y Avg
-1.66
5Y Avg
-1.49
Market Cap
$36.85M
Earnings Per Share (EPS)
-1.17
TTM Avg
-1.36
3Y Avg
-0.92
5Y Avg
-0.84
Market Cap
$36.31M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $38.98M | -2.33 | -7.80 | -4.68 | -3.46 |
| Nephros, Inc. (NEPH)vs › | $38.11M | 0.16 | 0.06 | -0.19 | -0.28 |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | -2.49 | -2.22 | -1.86 | -2.21 |
| Incannex Healthcare Limited (IXHL)vs › | $37.73M | N/A | -21.23 | -13.85 | -9.58 |
| Veru Inc. (VERU)vs › | $40.05M | -0.60 | -2.17 | -6.45 | -4.61 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.61M | -1.69 | -1.60 | -3.62 | -4.57 |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.47M | -0.87 | -1.21 | -1.66 | -1.49 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.85M | -1.17 | -1.36 | -0.92 | -0.84 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.31M | -2.13 | -3.42 | -5.72 | -5.72 |
| EUDA Health Holdings Limited (EUDA)vs › | $35.71M | -2.56 | -5.45 | -15.27 | -9.79 |
Trailing EPS (TTM)
$-2.33
Forward EPS (Est.)
$-0.38
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -12.80 |
| 2024-12-31 | -2.80 |
| 2023-12-31 | -0.81 |
| 2022-12-31 | -2.30 |
| 2021-12-31 | -0.07 |
| 2020-12-31 | -2.00 |
| 2019-12-31 | -1.20 |
| 2018-12-31 | -0.97 |
| 2017-12-31 | -0.26 |
| 2016-12-31 | -1.30 |
| 2015-12-31 | -5.70 |
| 2014-12-31 | 0.70 |
| 2013-12-31 | -0.60 |
| 2012-12-31 | 0.90 |
| 2011-12-31 | 1.30 |
| 2010-12-31 | 6.60 |
| 2009-12-31 | 2.40 |
| 2008-12-31 | 0.50 |
| 2007-12-31 | -0.44 |
| 2006-12-31 | -0.77 |
| 2005-12-31 | -10.50 |
| 2004-12-31 | 0.80 |
| 2003-12-31 | 1.40 |
| 2002-12-31 | 0.30 |
| 2001-12-31 | -2.00 |
| 2000-12-31 | -62.30 |
| 1999-12-31 | -52.50 |
| 1998-12-31 | -0.10 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T18:51:40.518Z. Historical observations retain their original dates. Historical series through 2011-03-16.
